VeriStrat validated in patients with non-small-cell lung cancer.
Department of Oncology, University of Alberta, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada. Electronic address: charles.butts@albertahealthservices.ca.
Charles A
CA
Butts
D001798:Blood Proteins / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D040901:Proteomics; D011799:Quinazolines / Q000627:therapeutic use*
D001798:Blood Proteins; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride